Last 12 months
Inside the activity.
0 purchase rows · 61 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 29 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 11 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2020 Filed Feb 15, 2020 00:26 UTC |
Pamiljans Janis GCVP, Pres, Aeronautics Systems
|
Exercise / conversionRestricted Performance Stock Rights · Derivative | 3,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002416 · doc4.xml · derivative · entry 6 Pamiljans Janis G · CIK 0001701037 · CVP, Pres, Aeronautics Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,188.05 Underlying: Common Stock · 3,572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 200% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. F5 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F5 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F8 · balance_after: Total amount includes 6,009 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 9,038 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; 6,961 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20; and 11,180.05 RPSRs granted on 4/1/17 with a measurement period ended on 12/31/19. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:26 UTC |
Pamiljans Janis GCVP, Pres, Aeronautics Systems
|
GrantRestricted Performance Stock Rights · Derivative | 9,580.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002416 · doc4.xml · derivative · entry 5 Pamiljans Janis G · CIK 0001701037 · CVP, Pres, Aeronautics Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,760.05 Underlying: Common Stock · 9,580.05 shares Expires not disclosed F5 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F6 · shares: The RPSRs acquired include (i) 1,786 vested RPSRs with respect to the measurement period ended 12/31/19 acquired due to settlement of the 2017 RPSRs held at 200% of the target award; (ii) 1,785.05 vested RPSRs with respect to the measurement period ended 12/31/19 acquired due to settlement of the 2017 RPSRs held at 119% of the target award; and (iii) 6,009 unvested RPSRs granted under the LTISP on 2/12/20 with a measurement period ending on 12/31/22. F5 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F5 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F7 · balance_after: Total amount includes 6,009 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 9,038 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; 6,961 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20; 11,180.05 RPSRs granted under the LTISP on 4/1/17 with a measurement period ended on 12/31/19; and 3,572 vested RPSRs granted under the LTISP on 2/17/17 with a measurement period ended on 12/31/19. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:26 UTC |
Pamiljans Janis GCVP, Pres, Aeronautics Systems
|
Tax withholdingCommon Stock | 6,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002416 · doc4.xml · nonDerivative · entry 3 Pamiljans Janis G · CIK 0001701037 · CVP, Pres, Aeronautics Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,972.2 F3 · shares: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e) Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:26 UTC |
Pamiljans Janis GCVP, Pres, Aeronautics Systems
|
Exercise / conversionCommon Stock | 3,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002416 · doc4.xml · nonDerivative · entry 2 Pamiljans Janis G · CIK 0001701037 · CVP, Pres, Aeronautics Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884.2 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 200% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:26 UTC |
Pamiljans Janis GCVP, Pres, Aeronautics Systems
|
Exercise / conversionCommon Stock | 11,180.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002416 · doc4.xml · nonDerivative · entry 1 Pamiljans Janis G · CIK 0001701037 · CVP, Pres, Aeronautics Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,312.2 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 119% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Kalan Lesley ACVP, Chief Strategy & Dev Ofc
|
GrantRestricted Stock Rights · Derivative | 1,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002414 · doc4.xml · derivative · entry 5 Kalan Lesley A · CIK 0001725864 · CVP, Chief Strategy & Dev Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,616 Underlying: Common Stock · 1,527 shares Expires not disclosed F7 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F7 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F7 · derivative.expiration_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F8 · balance_after: Total amount includes 1,527 RSRs granted under the LTISP on 2/12/20 that will vest on 2/12/23; 1,751 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; 1,445 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; and 893 RSRs granted under the LTISP on 2/17/17 that will vest on 2/18/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Kalan Lesley ACVP, Chief Strategy & Dev Ofc
|
Exercise / conversionRestricted Performance Stock Rights · Derivative | 4,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002414 · doc4.xml · derivative · entry 4 Kalan Lesley A · CIK 0001725864 · CVP, Chief Strategy & Dev Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,919 Underlying: Common Stock · 4,168 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 200% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. F3 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F6 · balance_after: Total amount includes 3,605 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 4,132 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; and 3,182 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Kalan Lesley ACVP, Chief Strategy & Dev Ofc
|
GrantRestricted Performance Stock Rights · Derivative | 5,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002414 · doc4.xml · derivative · entry 3 Kalan Lesley A · CIK 0001725864 · CVP, Chief Strategy & Dev Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,087 Underlying: Common Stock · 5,689 shares Expires not disclosed F3 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F4 · shares: The RPSRs acquired include (i) 2,084 vested RPSRs with respect to the measurement period ended 12/31/19 acquired due to settlement of the 2017 RPSRs held at 200% of the target award and (ii) 3,605 unvested RPSRs granted under the LTISP on 2/12/20 with a measurement period ending on 12/31/22. F3 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F5 · balance_after: Total amount includes 4,168 vested RPSRs granted under the LTISP on 2/17/17 with a measurement period ended on 12/31/19; 3,605 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 4,132 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; and 3,182 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Kalan Lesley ACVP, Chief Strategy & Dev Ofc
|
Tax withholdingCommon Stock | 1,481 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002414 · doc4.xml · nonDerivative · entry 2 Kalan Lesley A · CIK 0001725864 · CVP, Chief Strategy & Dev Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,867.89 F2 · shares: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e) Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Kalan Lesley ACVP, Chief Strategy & Dev Ofc
|
Exercise / conversionCommon Stock | 4,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002414 · doc4.xml · nonDerivative · entry 1 Kalan Lesley A · CIK 0001725864 · CVP, Chief Strategy & Dev Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,348.89 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 200% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
CHESTON SHEILA C.Corp. VP & General Counsel
|
GrantRestricted Stock Rights · Derivative | 2,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002412 · doc4.xml · derivative · entry 5 CHESTON SHEILA C. · CIK 0001499087 · Corp. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,588 Underlying: Common Stock · 2,206 shares Expires not disclosed F7 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F7 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F7 · derivative.expiration_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F8 · balance_after: Total amount includes 2,206 RSRs granted under the LTISP on 2/12/20 that will vest on 2/12/23; 2,845 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; 2,348 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; and 3,189 RSRs granted under the LTISP on 2/17/17 that will vest on 2/18/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
CHESTON SHEILA C.Corp. VP & General Counsel
|
Exercise / conversionRestricted Performance Stock Rights · Derivative | 9,074.94 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002412 · doc4.xml · derivative · entry 4 CHESTON SHEILA C. · CIK 0001499087 · Corp. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,092 Underlying: Common Stock · 9,074.94 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 119% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. F3 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F6 · balance_after: Total amount includes 5,207 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 6,714 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; and 5,171 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
CHESTON SHEILA C.Corp. VP & General Counsel
|
GrantRestricted Performance Stock Rights · Derivative | 6,655.94 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002412 · doc4.xml · derivative · entry 3 CHESTON SHEILA C. · CIK 0001499087 · Corp. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,166.94 Underlying: Common Stock · 6,655.94 shares Expires not disclosed F3 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F4 · shares: The RPSRs acquired include (i) 1,448.94 vested RPSRs with respect to the measurement period ended 12/31/19 acquired due to settlement of the 2017 RPSRs held at 119% of the target award and (ii) 5,207 unvested RPSRs granted under the LTISP on 2/12/20 with a measurement period ending on 12/31/22. F3 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F5 · balance_after: Total amount includes 9,074.94 vested RPSRs granted under the LTISP on 2/17/17 with a measurement period ended on 12/31/19; 5,207 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 6,714 RPSRs granted on 12/31/19 with a measurement period ending on 12/31/21; and 5,171 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
CHESTON SHEILA C.Corp. VP & General Counsel
|
Tax withholdingCommon Stock | 3,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002412 · doc4.xml · nonDerivative · entry 2 CHESTON SHEILA C. · CIK 0001499087 · Corp. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,842.31 F2 · shares: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e) Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
CHESTON SHEILA C.Corp. VP & General Counsel
|
Exercise / conversionCommon Stock | 9,074.94 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002412 · doc4.xml · nonDerivative · entry 1 CHESTON SHEILA C. · CIK 0001499087 · Corp. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,822.31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 119% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Hardesty Michael ACorp VP, Controller & CAO
|
GrantRestricted Stock Rights · Derivative | 594 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002413 · doc4.xml · derivative · entry 5 Hardesty Michael A · CIK 0001569355 · Corp VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,757 Underlying: Common Stock · 594 shares Expires not disclosed F7 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F7 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F7 · derivative.expiration_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F8 · balance_after: Total amount includes 594 RSRs granted under the LTISP on 2/12/20 that will vest on 2/12/23; 766 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; 632 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; and 765 RSRs granted under the LTISP on 2/17/17 that will vest on 2/18/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Hardesty Michael ACorp VP, Controller & CAO
|
Exercise / conversionRestricted Performance Stock Rights · Derivative | 3,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002413 · doc4.xml · derivative · entry 4 Hardesty Michael A · CIK 0001569355 · Corp VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,649 Underlying: Common Stock · 3,572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 200% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. F3 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F6 · balance_after: Total amount includes 1,386 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 1,788 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; and 1,475 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Hardesty Michael ACorp VP, Controller & CAO
|
GrantRestricted Performance Stock Rights · Derivative | 3,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002413 · doc4.xml · derivative · entry 3 Hardesty Michael A · CIK 0001569355 · Corp VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,221 Underlying: Common Stock · 3,172 shares Expires not disclosed F3 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F4 · shares: The RPSRs acquired include (i) 1,786 vested RPSRs with respect to the measurement period ended 12/31/19 acquired due to settlement of the 2017 RPSRs held at 200% of the target award and (ii) 1,386 unvested RPSRs granted under the LTISP on 2/12/20 with a measurement period ending on 12/31/22. F3 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F5 · balance_after: Total amount includes 3,572 vested RPSRs granted under the LTISP on 2/17/17 with a measurement period ended on 12/31/19; 1,386 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 1,788 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; and 1,475 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Hardesty Michael ACorp VP, Controller & CAO
|
Tax withholdingCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002413 · doc4.xml · nonDerivative · entry 2 Hardesty Michael A · CIK 0001569355 · Corp VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,163.2 F2 · shares: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e) Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Hardesty Michael ACorp VP, Controller & CAO
|
Exercise / conversionCommon Stock | 3,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002413 · doc4.xml · nonDerivative · entry 1 Hardesty Michael A · CIK 0001569355 · Corp VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,378.2 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 200% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Caylor Mark ACVP & Pres, Mission Systems
|
GrantRestricted Stock Rights · Derivative | 2,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002411 · doc4.xml · derivative · entry 6 Caylor Mark A · CIK 0001559097 · CVP & Pres, Mission Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,380 Underlying: Common Stock · 2,545 shares Expires not disclosed F8 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F8 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F8 · derivative.expiration_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F9 · balance_after: Total amount includes 2,545 RSRs granted under the LTISP on 2/12/20 that will vest on 2/12/23; 3,830 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; 1,655 RSRs granted under the LTISP on 12/4/18 that will vest on 12/4/21; 3,161 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; and 3,189 RSRs granted under the LTISP on 2/17/17 that will vest on 2/18/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Caylor Mark ACVP & Pres, Mission Systems
|
Exercise / conversionRestricted Performance Stock Rights · Derivative | 9,074.94 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002411 · doc4.xml · derivative · entry 5 Caylor Mark A · CIK 0001559097 · CVP & Pres, Mission Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,008 Underlying: Common Stock · 9,074.94 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 119% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. F4 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F4 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F7 · balance_after: Total amount includes 6,009 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 9,038 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; and 6,961 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Caylor Mark ACVP & Pres, Mission Systems
|
GrantRestricted Performance Stock Rights · Derivative | 7,457.94 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002411 · doc4.xml · derivative · entry 4 Caylor Mark A · CIK 0001559097 · CVP & Pres, Mission Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,082.94 Underlying: Common Stock · 7,457.94 shares Expires not disclosed F4 · derivative.exercise_price: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F5 · shares: The RPSRs acquired include (i) 1,448.94 vested RPSRs with respect to the measurement period ended 12/31/19 acquired due to settlement of the 2017 RPSRs held at 119% of the target award and (ii) 6,009 unvested RPSRs granted under the LTISP on 2/12/20 with a measurement period ending on 12/31/22. F4 · derivative.exercise_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F4 · derivative.expiration_date: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F6 · balance_after: Total amount includes 9,074.94 vested RPSRs granted under the LTISP on 2/17/17 with a measurement period ended on 12/31/19; 6,009 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 9,038 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; and 6,961 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Caylor Mark ACVP & Pres, Mission Systems
|
Tax withholdingCommon Stock | 3,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002411 · doc4.xml · nonDerivative · entry 2 Caylor Mark A · CIK 0001559097 · CVP & Pres, Mission Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,974.1 F2 · shares: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e) Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Caylor Mark ACVP & Pres, Mission Systems
|
Exercise / conversionCommon Stock | 9,074.94 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002411 · doc4.xml · nonDerivative · entry 1 Caylor Mark A · CIK 0001559097 · CVP & Pres, Mission Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,954.1 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/17/17 with a valuation of performance measurement period ("measurement period") that ended 12/31/19. RPSRs to be settled at 119% of target. The shares are anticipated to be distributed into the participant's account on February 14, 2020. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Addison Ann MCorp VP & Chief HR Officer
|
GrantRestricted Stock Rights · Derivative | 1,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002410 · doc4.xml · derivative · entry 2 Addison Ann M · CIK 0001682425 · Corp VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,169 Underlying: Common Stock · 1,527 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F4 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F4 · derivative.expiration_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/12/20 and will vest on 2/12/23. F5 · balance_after: Total amount includes 1,527 RSRs granted under the LTISP on 2/12/20 that will vest on 2/12/23; 1,751 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; and 891 RSRs granted under the LTISP on 10/30/18 that will vest on 10/30/21. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:25 UTC |
Addison Ann MCorp VP & Chief HR Officer
|
GrantRestricted Performance Stock Rights · Derivative | 3,605 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002410 · doc4.xml · derivative · entry 1 Addison Ann M · CIK 0001682425 · Corp VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,353 Underlying: Common Stock · 3,605 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · shares: These unvested RPSRs were granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/12/20 with a measurement period ending on 12/31/22. F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · balance_after: Total amount includes 3,605 RPSRs granted on 2/12/20 with a measurement period ending on 12/31/22; 4,132 RPSRs granted on 2/13/19 with a measurement period ending on 12/31/21; and 2,616 RPSRs granted on 10/31/18 with a measurement period ending on 12/31/20. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 22:01 UTC |
Petryszyn Mary DCVP, Pres, Defense Systems
|
SaleCommon Stock | 3,921 | $362.27 | $1,420,460.67 |
DisclosureSEC source: 0001225208-20-001944 · doc4.xml · nonDerivative · entry 1 Petryszyn Mary D · CIK 0001791724 · CVP, Pres, Defense Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,712.72 F1 · price: Represents the weighted average sale price of $362.27 rounded to the nearest hundredth. The highest price at which the shares were sold was $362.33 and the lowest price at which the shares were sold was $362.258. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| February 03, 2020 Filed Feb 4, 2020 22:41 UTC |
Bedingfield Kenneth LCorp VP, CFO
|
SaleCommon Stock | 4,611 | $367.33 | $1,693,758.63 |
DisclosureSEC source: 0001225208-20-001588 · doc4.xml · nonDerivative · entry 1 Bedingfield Kenneth L · CIK 0001539147 · Corp VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,393.82 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:15 UTC |
Brown MarianneDirector
|
GrantCommon Stock | 95 | $343.97 | $32,677.15 |
DisclosureSEC source: 0001225208-20-000263 · doc4.xml · nonDerivative · entry 1 Brown Marianne · CIK 0001600605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,367 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:15 UTC |
Larson Blake ECVP & Pres, NG Space Systems
|
Exercise / conversionRestricted Stock Rights · Derivative | 5,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000266 · doc4.xml · derivative · entry 3 Larson Blake E · CIK 0001313857 · CVP & Pres, NG Space Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,114 Underlying: Common Stock · 5,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F1 · shares: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 6/13/18 that vested on 12/31/19. F3 · derivative.exercise_date: Each RSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F1 · derivative.expiration_date: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 6/13/18 that vested on 12/31/19. F4 · balance_after: Total amount includes 2,831 RSRs granted under the LTISP on 6/13/18 that will vest on 6/13/21; and 3,283 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:15 UTC |
Larson Blake ECVP & Pres, NG Space Systems
|
Tax withholdingCommon Stock | 2,112 | $343.97 | $726,464.64 |
DisclosureSEC source: 0001225208-20-000266 · doc4.xml · nonDerivative · entry 2 Larson Blake E · CIK 0001313857 · CVP & Pres, NG Space Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,989 F2 · shares: Shares surrendered to issuer in payment of tax liability in connection with vesting of RSRs in accordance with Rule 16b-3(e). Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:15 UTC |
Larson Blake ECVP & Pres, NG Space Systems
|
Exercise / conversionCommon Stock | 5,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000266 · doc4.xml · nonDerivative · entry 1 Larson Blake E · CIK 0001313857 · CVP & Pres, NG Space Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 6/13/18 that vested on 12/31/19. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:15 UTC |
KRAPEK KARL JDirector
|
GrantCommon Stock | 95 | $343.97 | $32,677.15 |
DisclosureSEC source: 0001225208-20-000264 · doc4.xml · nonDerivative · entry 1 KRAPEK KARL J · CIK 0001238288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,679 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Total amount includes (i) 4,856 shares of common stock and (ii) 22,823 shares of common stock, including dividends, held in a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan and the 1993 Stock Plan for Non-Employee Directors. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 20:05 UTC |
Addison Ann MCorp VP & Chief HR Officer
|
Exercise / conversionRestricted Stock Rights · Derivative | 5,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-013987 · doc4.xml · derivative · entry 4 Addison Ann M · CIK 0001682425 · Corp VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,642 Underlying: Common Stock · 5,146 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F1 · shares: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 10/30/18 that vested on 10/30/19. F4 · derivative.exercise_date: Each RSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F1 · derivative.expiration_date: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 10/30/18 that vested on 10/30/19. F5 · balance_after: Total amount includes 1,751 RSRs granted under the LTISP on 2/13/19 that will vest on 2/13/22; and 891 RSRs granted under the LTISP on 10/30/18 that will vest on 10/30/21. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 20:05 UTC |
Addison Ann MCorp VP & Chief HR Officer
|
Tax withholdingCommon Stock | 2,398 | $354.08 | $849,083.84 |
DisclosureSEC source: 0001225208-19-013987 · doc4.xml · nonDerivative · entry 2 Addison Ann M · CIK 0001682425 · Corp VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,748 F2 · shares: Shares surrendered to issuer in payment of tax liability in connection with vesting of RSRs in accordance with Rule 16b-3(e). Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 20:05 UTC |
Addison Ann MCorp VP & Chief HR Officer
|
Exercise / conversionCommon Stock | 5,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-013987 · doc4.xml · nonDerivative · entry 1 Addison Ann M · CIK 0001682425 · Corp VP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares issued upon vesting of Restricted Stock Rights ("RSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 10/30/18 that vested on 10/30/19. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:44 UTC |
KRAPEK KARL JDirector
|
GrantCommon Stock | 86 | $374.79 | $32,231.94 |
DisclosureSEC source: 0001225208-19-013036 · doc4.xml · nonDerivative · entry 1 KRAPEK KARL J · CIK 0001238288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Total amount includes (i) 4,856 shares of common stock; and (ii) 22,644 shares of common stock, including dividends, held in a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan and the 1993 Stock Plan for Non-Employee Directors. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:44 UTC |
Brown MarianneDirector
|
GrantCommon Stock | 86 | $374.79 | $32,231.94 |
DisclosureSEC source: 0001225208-19-013035 · doc4.xml · nonDerivative · entry 1 Brown Marianne · CIK 0001600605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,252 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reported under Rule 16a-11. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 20:32 UTC |
Jones Christopher TCorp VP & Pres Tech Svcs
|
GiftCommon Stock | 72 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-011787 · doc4.xml · nonDerivative · entry 1 Jones Christopher T · CIK 0001559104 · Corp VP & Pres Tech Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,828.899 Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 21:42 UTC |
Jones Christopher TCorp VP & Pres Tech Svcs
|
GiftCommon Stock | 72 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-011693 · doc4.xml · nonDerivative · entry 1 Jones Christopher T · CIK 0001559104 · Corp VP & Pres Tech Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,900.899 Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:03 UTC |
Warden Kathy JDirector · CEO and President
|
SaleCommon Stock | 2,732 | $353.19 | $964,915.08 |
DisclosureSEC source: 0001225208-19-010726 · doc4.xml · nonDerivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,894.85 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: Represents the weighted average sale price of $353.19 rounded to the nearest hundredth. The highest price at which the shares were sold was $353.67 and the lowest price at which the shares were sold was $352.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:03 UTC |
Warden Kathy JDirector · CEO and President
|
SaleCommon Stock | 1,975 | $354.15 | $699,446.25 |
DisclosureSEC source: 0001225208-19-010726 · doc4.xml · nonDerivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,626.85 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: Represents the weighted average sale price of $354.15 rounded to the nearest hundredth. The highest price at which the shares were sold was $354.62 and the lowest price at which the shares were sold was $353.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:03 UTC |
Warden Kathy JDirector · CEO and President
|
SaleCommon Stock | 1,400 | $352.09 | $492,926.00 |
DisclosureSEC source: 0001225208-19-010726 · doc4.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,601.85 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: Represents the weighted average sale price of $352.09 rounded to the nearest hundredth. The highest price at which the shares were sold was $352.485 and the lowest price at which the shares were sold was $351.52. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:03 UTC |
Warden Kathy JDirector · CEO and President
|
SaleCommon Stock | 730 | $355.21 | $259,303.30 |
DisclosureSEC source: 0001225208-19-010726 · doc4.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,001.85 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price of $355.21 rounded to the nearest hundredth. The highest price at which the shares were sold was $355.60 and the lowest price at which the shares were sold was $354.85. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:02 UTC |
Jones Christopher TCorp VP & Pres Tech Svcs
|
SaleCommon Stock | 2,770 | $353.07 | $978,003.90 |
DisclosureSEC source: 0001225208-19-010724 · doc4.xml · nonDerivative · entry 4 Jones Christopher T · CIK 0001559104 · Corp VP & Pres Tech Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,972.899 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: Represents the weighted average sale price of $353.07 rounded to the nearest hundredth. The highest price at which the shares were sold was $353.47 and the lowest price at which the shares were sold was $352.48. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:02 UTC |
Jones Christopher TCorp VP & Pres Tech Svcs
|
SaleCommon Stock | 1,100 | $352.05 | $387,255.00 |
DisclosureSEC source: 0001225208-19-010724 · doc4.xml · nonDerivative · entry 3 Jones Christopher T · CIK 0001559104 · Corp VP & Pres Tech Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,742.899 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: Represents the weighted average sale price of $352.05 rounded to the nearest hundredth. The highest price at which the shares were sold was $352.345 and the lowest price at which the shares were sold was $351.47. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:02 UTC |
Jones Christopher TCorp VP & Pres Tech Svcs
|
SaleCommon Stock | 579 | $353.86 | $204,884.94 |
DisclosureSEC source: 0001225208-19-010724 · doc4.xml · nonDerivative · entry 2 Jones Christopher T · CIK 0001559104 · Corp VP & Pres Tech Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,842.899 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: Represents the weighted average sale price of $353.86 rounded to the nearest hundredth. The highest price at which the shares were sold was $354.10 and the lowest price at which the shares were sold was $353.57. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:02 UTC |
Jones Christopher TCorp VP & Pres Tech Svcs
|
SaleCommon Stock | 551 | $355.39 | $195,819.89 |
DisclosureSEC source: 0001225208-19-010724 · doc4.xml · nonDerivative · entry 1 Jones Christopher T · CIK 0001559104 · Corp VP & Pres Tech Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,421.899 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price of $355.39 rounded to the nearest hundredth. The highest price at which the shares were sold was $355.78 and the lowest price at which the shares were sold was $355.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:04 UTC |
Brown MarianneDirector
|
GrantCommon Stock | 101 | $323.11 | $32,634.11 |
DisclosureSEC source: 0001225208-19-009807 · doc4.xml · nonDerivative · entry 1 Brown Marianne · CIK 0001600605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,147 F1 · kind: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F1 · shares: Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan (the "Plan") in a transaction exempt pursuant to Rule 16b-3. F2 · balance_after: Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.